Ambroxol ‘ASPro-PD’: registration of interest
Everyone expressing an interest in taking part in the large phase 3 ASPro-PD ambroxol trial will be genetically screened, via PD Frontline, as part of the trial selection criteria. PD Frontline are currently prioritising people under the age of 75 who have been diagnosed with Parkinson’s.
Registration of interest form:
Please note that this process can take several months from completion of the PD Frontline application to receiving your results. We also ask you to complete this form to register your interest with us. This will help you stay up-to-date with Cure Parkinson’s research and fundraising news and direct you on to PD Frontline.